For those exploring whether microdosing GLP-1 medications for autoimmune conditions has merit, some emerging research suggests anti-inflammatory benefits at lower doses, though this remains investigational
Semaglutide works by reducing appetite, delaying gastric emptying, increasing insulin release, and lowering the amount of glucagon released
These options may include injectable products and noninjectable products, such as orally disintegrating tablets (tablets that dissolve in the mouth), sublingual tablets (tablets placed under the tongue to dissolve), or oral drops
Insulin resistance, a common condition in individuals with obesity, can lead to further weight gain and contribute to the development of type 2 diabetes
Semaglutide is available in both injectable and oral forms